Homology Medicines, Inc.
Step 1
Step 1
A patient could receive a one-time intravenous (I.V.) administration of HMI-203.
MENU
We are Homology
We Are Homology
Leadership
Board of Directors
Scientific Advisory Board
Technology Platform
AAVHSC Platform
Gene Therapy
Gene Editing
GTx-mAb
Publications and Presentations
Pipeline
Patients & Families
Community Involvement
Patient Stories
Ava’s Story
Tia’s Story
Expanded Access Policy
Clinical Trials
Overview
Gene Editing Clinical Trial for PKU
Gene Therapy Clinical Trial for MPS II
Culture & Careers
Investors
Overview
Stock Information
Stock Quote & Chart
Historical Price Lookup
Stock Calculator
News & Events
News Releases
Investor Calendar
Presentations
Financial Information
SEC Filings
Annual Reports
Analyst Coverage
Corporate Governance
Governance Highlights
Management Team
Board of Directors
Committee Composition
Investor Resources
Email Alerts
Contact IR